We performed an open , international , multicenter trial involving women at 14 weeks 0 days to 33 weeks 6 days of gestation who had nonproteinuric preexisting or gestational hypertension , office diastolic blood pressure of 90 to 105 mm Hg ( or 85 to 105 mm Hg if the woman was taking antihypertensive medications ) , and a live fetus .